Rangaswamy Akhanda Chintapatla, MD - Medicare Medical Oncology in Kennewick, WA

Rangaswamy Akhanda Chintapatla, MD is a medicare enrolled "Internal Medicine - Medical Oncology" physician in Kennewick, Washington. He graduated from medical school in 2004 and has 20 years of diverse experience with area of expertise as Medical Oncology. He is a member of the group practice Kadlec Regional Medical Center, Kadlec Regional Medical Center and his current practice location is 7350 W Deschutes Ave Ste B103, Kennewick, Washington. You can reach out to his office (for appointments etc.) via phone at (509) 783-0144.

Rangaswamy Akhanda Chintapatla is licensed to practice in Washington (license number MD60455869) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1003131640.

Contact Information

Rangaswamy Akhanda Chintapatla, MD
7350 W Deschutes Ave Ste B103,
Kennewick, WA 99336-7802
(509) 783-0144
(509) 783-8244



Physician's Profile

Full NameRangaswamy Akhanda Chintapatla
GenderMale
SpecialityMedical Oncology
Experience20 Years
Location7350 W Deschutes Ave Ste B103, Kennewick, Washington
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Rangaswamy Akhanda Chintapatla graduated from medical school in 2004
  NPI Data:
  • NPI Number: 1003131640
  • Provider Enumeration Date: 04/06/2010
  • Last Update Date: 12/29/2021
  Medicare PECOS Information:
  • PECOS PAC ID: 0042334237
  • Enrollment ID: I20140604001585

Medical Identifiers

Medical identifiers for Rangaswamy Akhanda Chintapatla such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1003131640NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207RX0202XInternal Medicine - Medical Oncology MD60455869 (Washington)Primary
207RH0003XInternal Medicine - Hematology & Oncology MD60455869 (Washington)Secondary
207R00000XInternal Medicine MD60455869 (Washington)Secondary
207RH0000XInternal Medicine - Hematology MD60455869 (Washington)Secondary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Kadlec Regional Medical CenterRichland, WAHospital
Grande Ronde HospitalLa grande, ORHospital
Good Shepherd Medical CenterHermiston, ORHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Kadlec Regional Medical Center9739098617338
Kadlec Regional Medical Center9739098617338

News Archive

Differences in timing of stem cells turning into cartilage play major role in shaping the face

Timing is everything when it comes to the development of the vertebrate face. In a new study published in PLoS Genetics, USC Stem Cell researcher Lindsey Barske from the laboratory of Gage Crump and her colleagues identify the roles of key molecular signals that control this critical timing.

Abbvie announces multiple study results of veliparib investigational compound in NSCLC patients

AbbVie released interim results from an ongoing Phase 2 study of its investigational compound veliparib in combination with chemotherapy, which showed a 35 percent improvement (P-value=0.14) in progression-free survival (PFS) and a 30 percent improvement (P-value=0.21) in overall survival (OS) in patients with previously untreated metastatic or advanced non-small cell lung cancer (NSCLC).

Alarming trends in sexually transmitted diseases (STDs) among America's young people

A study by ASHA, sponsored by Roche Diagnostics of Indianapolis, Indiana is being released in conjunction with April's STD Awareness Month and demonstrates that the incident rate of STDS in youth (ages 15-24) have increased dramatically in recent years.

FDA approves Endo's BELBUCA (buprenorphine) buccal film for use in patients with chronic pain

Endo Pharmaceuticals Inc., a subsidiary of Endo International plc, and BioDelivery Sciences International, Inc., announced today that the U.S. Food and Drug Administration (FDA) has approved BELBUCA (buprenorphine) buccal film for use in patients with chronic pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate.

Wake Forest Baptist scientists use pre-clinical model to develop a safe, effective flu vaccine for infants

Newborns and young infants are particularly susceptible to the flu and are six times more likely to die from the infection than older children. Currently there is no flu vaccine available for babies less than 6 months old.

Read more Medical News

› Verified 1 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Rangaswamy Akhanda Chintapatla allows following entities to bill medicare on his behalf.
Entity NameKadlec Regional Medical Center
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1972507580
PECOS PAC ID: 9739098617
Enrollment ID: O20031104000035

News Archive

Differences in timing of stem cells turning into cartilage play major role in shaping the face

Timing is everything when it comes to the development of the vertebrate face. In a new study published in PLoS Genetics, USC Stem Cell researcher Lindsey Barske from the laboratory of Gage Crump and her colleagues identify the roles of key molecular signals that control this critical timing.

Abbvie announces multiple study results of veliparib investigational compound in NSCLC patients

AbbVie released interim results from an ongoing Phase 2 study of its investigational compound veliparib in combination with chemotherapy, which showed a 35 percent improvement (P-value=0.14) in progression-free survival (PFS) and a 30 percent improvement (P-value=0.21) in overall survival (OS) in patients with previously untreated metastatic or advanced non-small cell lung cancer (NSCLC).

Alarming trends in sexually transmitted diseases (STDs) among America's young people

A study by ASHA, sponsored by Roche Diagnostics of Indianapolis, Indiana is being released in conjunction with April's STD Awareness Month and demonstrates that the incident rate of STDS in youth (ages 15-24) have increased dramatically in recent years.

FDA approves Endo's BELBUCA (buprenorphine) buccal film for use in patients with chronic pain

Endo Pharmaceuticals Inc., a subsidiary of Endo International plc, and BioDelivery Sciences International, Inc., announced today that the U.S. Food and Drug Administration (FDA) has approved BELBUCA (buprenorphine) buccal film for use in patients with chronic pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate.

Wake Forest Baptist scientists use pre-clinical model to develop a safe, effective flu vaccine for infants

Newborns and young infants are particularly susceptible to the flu and are six times more likely to die from the infection than older children. Currently there is no flu vaccine available for babies less than 6 months old.

Read more Medical News

› Verified 1 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Rangaswamy Akhanda Chintapatla is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Rangaswamy Akhanda Chintapatla, MD
550 Gage Blvd Ste 101,
Richland, WA 99352-9532

Ph: (509) 942-3627
Rangaswamy Akhanda Chintapatla, MD
7350 W Deschutes Ave Ste B103,
Kennewick, WA 99336-7802

Ph: (509) 783-0144

News Archive

Differences in timing of stem cells turning into cartilage play major role in shaping the face

Timing is everything when it comes to the development of the vertebrate face. In a new study published in PLoS Genetics, USC Stem Cell researcher Lindsey Barske from the laboratory of Gage Crump and her colleagues identify the roles of key molecular signals that control this critical timing.

Abbvie announces multiple study results of veliparib investigational compound in NSCLC patients

AbbVie released interim results from an ongoing Phase 2 study of its investigational compound veliparib in combination with chemotherapy, which showed a 35 percent improvement (P-value=0.14) in progression-free survival (PFS) and a 30 percent improvement (P-value=0.21) in overall survival (OS) in patients with previously untreated metastatic or advanced non-small cell lung cancer (NSCLC).

Alarming trends in sexually transmitted diseases (STDs) among America's young people

A study by ASHA, sponsored by Roche Diagnostics of Indianapolis, Indiana is being released in conjunction with April's STD Awareness Month and demonstrates that the incident rate of STDS in youth (ages 15-24) have increased dramatically in recent years.

FDA approves Endo's BELBUCA (buprenorphine) buccal film for use in patients with chronic pain

Endo Pharmaceuticals Inc., a subsidiary of Endo International plc, and BioDelivery Sciences International, Inc., announced today that the U.S. Food and Drug Administration (FDA) has approved BELBUCA (buprenorphine) buccal film for use in patients with chronic pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate.

Wake Forest Baptist scientists use pre-clinical model to develop a safe, effective flu vaccine for infants

Newborns and young infants are particularly susceptible to the flu and are six times more likely to die from the infection than older children. Currently there is no flu vaccine available for babies less than 6 months old.

Read more News

› Verified 1 days ago


Internal Medicine Doctors in Kennewick, WA

Joel Ohrt, RESIDENT PHYSICIAN
Internal Medicine
Medicare: Medicare Enrolled
Practice Location: 216 W 10th Ave Ste 204, Kennewick, WA 99336
Phone: 509-221-5677    
David Marcelino Sandoval, MD
Internal Medicine
Medicare: Not Enrolled in Medicare
Practice Location: 6710 W Okanogan Place, Kennewick, WA 99336
Phone: 509-783-2000    Fax: 509-783-2008
Dr. Elizabeth Clare Doolin, DO
Internal Medicine
Medicare: Medicare Enrolled
Practice Location: 216 W 10th Ave Ste 202, Kennewick, WA 99336
Phone: 509-221-5510    
Carlos Ramirez Babinski, MD
Internal Medicine
Medicare: Medicare Enrolled
Practice Location: 3810 Plaza Way, Kennewick, WA 99338
Phone: 509-221-5510    
Ying Zhuo, M.D.
Internal Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 7360 W Deschutes Ave, Kennewick, WA 99336
Phone: 509-783-0144    
Richard G Marquardt Ii, M.D.
Internal Medicine
Medicare: Not Enrolled in Medicare
Practice Location: 195706 E 30th Ave, Kennewick, WA 99337
Phone: 509-582-6057    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.